- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
T3 Pharmaceuticals AG
Headquarters: Basel, Switzerland
Website: N/A
Year Founded: 2015
Status: Acquired
BioCentury | Nov 22, 2023
Deals
Nov. 22 Quick Takes: Boehringer buying bacterial oncology play T3
Plus: Syncona reaches deal to take Freeline private, and updates from InDex, Evelo and more
BioCentury | Aug 1, 2020
Translation in Brief
TScan identifies CD8+ T cell COVID-19 epitopes, plus T3 gears up for Phase I of bacterial cancer therapy, a wearable device to monitor PK and a COVID-19 vaccine
BioCentury’s roundup of preclinical news
BioCentury | Sep 27, 2019
Financial News
Sept. 27 Financial Quick Takes: Beam hops into IPO queue; plus Amryt, T3, Junshi, Newronika
Items per page:
1 - 3 of 3